Equillium Stock EBITDA

EQ Stock  USD 2.31  0.25  12.14%   
Equillium fundamentals help investors to digest information that contributes to Equillium's financial success or failures. It also enables traders to predict the movement of Equillium Stock. The fundamental analysis module provides a way to measure Equillium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Equillium stock.
As of 03/29/2024, EBITDA is likely to drop to about (15.2 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Equillium EBITDA Analysis

Equillium's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Equillium Ebitda

(15.25 Million)

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Equillium EBITDA

    
  (14.52 M)  
Most of Equillium's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Equillium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Equillium EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as EBITDA. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.
0.310.920.570.96-0.87-0.730.55-0.380.650.90.840.90.550.76-0.911.00.9-0.850.810.520.350.690.80.29
0.310.30.410.46-0.09-0.37-0.370.140.50.360.450.34-0.130.06-0.470.310.21-0.680.310.29-0.610.290.410.64
0.920.30.270.96-0.71-0.440.27-0.340.560.750.670.720.240.8-0.950.920.99-0.810.590.190.120.430.640.02
0.570.410.270.44-0.75-0.930.61-0.310.560.760.750.810.770.02-0.330.560.22-0.540.820.890.440.860.690.69
0.960.460.960.44-0.75-0.60.31-0.370.690.820.770.80.310.79-0.970.960.92-0.920.690.390.090.550.710.29
-0.87-0.09-0.71-0.75-0.750.79-0.730.59-0.55-0.87-0.75-0.89-0.72-0.460.64-0.86-0.70.62-0.82-0.63-0.63-0.76-0.67-0.26
-0.73-0.37-0.44-0.93-0.60.79-0.720.37-0.66-0.89-0.91-0.93-0.85-0.330.49-0.73-0.390.69-0.95-0.94-0.49-0.96-0.85-0.67
0.55-0.370.270.610.31-0.73-0.72-0.480.320.630.590.690.930.36-0.20.540.29-0.230.720.720.930.730.560.2
-0.380.14-0.34-0.31-0.370.590.37-0.48-0.54-0.42-0.36-0.44-0.3-0.420.25-0.38-0.270.33-0.44-0.45-0.41-0.4-0.14-0.17
0.650.50.560.560.69-0.55-0.660.32-0.540.690.750.70.340.53-0.70.650.47-0.860.660.630.070.570.660.57
0.90.360.750.760.82-0.87-0.890.63-0.420.690.970.990.740.55-0.730.890.72-0.810.970.710.420.910.930.36
0.840.450.670.750.77-0.75-0.910.59-0.360.750.970.970.720.56-0.70.840.63-0.840.970.770.320.930.960.49
0.90.340.720.810.8-0.89-0.930.69-0.440.70.990.970.780.54-0.710.890.68-0.80.980.770.470.930.920.43
0.55-0.130.240.770.31-0.72-0.850.93-0.30.340.740.720.780.21-0.20.550.26-0.30.830.80.830.870.730.31
0.760.060.80.020.79-0.46-0.330.36-0.420.530.550.560.540.21-0.790.770.79-0.690.480.230.150.340.510.08
-0.91-0.47-0.95-0.33-0.970.640.49-0.20.25-0.7-0.73-0.7-0.71-0.2-0.79-0.91-0.920.91-0.58-0.270.0-0.42-0.68-0.23
1.00.310.920.560.96-0.86-0.730.54-0.380.650.890.840.890.550.77-0.910.9-0.850.80.520.350.680.80.29
0.90.210.990.220.92-0.7-0.390.29-0.270.470.720.630.680.260.79-0.920.9-0.730.560.120.170.40.63-0.09
-0.85-0.68-0.81-0.54-0.920.620.69-0.230.33-0.86-0.81-0.84-0.8-0.3-0.690.91-0.85-0.73-0.73-0.550.06-0.61-0.78-0.54
0.810.310.590.820.69-0.82-0.950.72-0.440.660.970.970.980.830.48-0.580.80.56-0.730.830.490.980.920.46
0.520.290.190.890.39-0.63-0.940.72-0.450.630.710.770.770.80.23-0.270.520.12-0.550.830.480.880.670.79
0.35-0.610.120.440.09-0.63-0.490.93-0.410.070.420.320.470.830.150.00.350.170.060.490.480.510.32-0.07
0.690.290.430.860.55-0.76-0.960.73-0.40.570.910.930.930.870.34-0.420.680.4-0.610.980.880.510.870.51
0.80.410.640.690.71-0.67-0.850.56-0.140.660.930.960.920.730.51-0.680.80.63-0.780.920.670.320.870.38
0.290.640.020.690.29-0.26-0.670.2-0.170.570.360.490.430.310.08-0.230.29-0.09-0.540.460.79-0.070.510.38
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Equillium Ebitda

Ebitda

(15.25 Million)

Equillium reported last year EBITDA of (14.52 Million)
According to the company disclosure, Equillium reported earnings before interest,tax, depreciation and amortization of (14.52 Million). This is 101.66% lower than that of the Biotechnology sector and 114.5% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.37% higher than that of the company.

Equillium EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Equillium's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Equillium could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics of similar companies.
Equillium is currently under evaluation in ebitda category among related companies.

Equillium Institutional Holders

Institutional Holdings refers to the ownership stake in Equillium that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Equillium's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Equillium's value.
Shares
Citadel Advisors Llc2023-09-30
47 K
Integrated Wealth Concepts Llc2023-12-31
40 K
Northern Trust Corp2023-12-31
35.2 K
Millennium Management Llc2023-12-31
24.7 K
Capital Cs Group, Llc2023-12-31
19 K
Tower Research Capital Llc2023-12-31
9.4 K
Adar1 Capital Management Llc2023-12-31
6.5 K
Blackrock Inc2023-12-31
3.8 K
Wells Fargo & Co2023-12-31
1.1 K
Decheng Capital Llc2023-12-31
4.4 M
Vanguard Group Inc2023-12-31
836.9 K

Equillium Fundamentals

About Equillium Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
EBITDA-14.5 M-15.2 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Equillium in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Equillium's short interest history, or implied volatility extrapolated from Equillium options trading.

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

  0.8VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.78MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.76KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.76ME 23Andme HoldingPairCorr
  0.75MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Equillium Piotroski F Score and Equillium Altman Z Score analysis.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.38)
Revenue Per Share
1.039
Quarterly Revenue Growth
(0.42)
Return On Assets
(0.14)
Return On Equity
(0.49)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.